Create was founded by Daniel Getts in 2020.

Who are Create's investors?

Create's investors include 8VC, Raptor Group, Newpath Partners.

How much funding has Create raised?

Create has disclosed $2M raised across 1 round.

Where is Create headquartered?

Create is headquartered in San Francisco, US.

Create

San Francisco, US · Founded 2020 · Delaware corporation · 3 known investors

Find your way into Create

250 people in our graph share verified history with the Create team — schools, employers, funds. One of them is your warm intro.

Liz Westhouseunlockedknows Daniel Getts · together at Northwestern University (overlapped)

×8knows the team · via University of Sydney

knows the team · via Western Michigan University - Haworth College of Business

×2knows the team · via Northwestern University

CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Create was founded in 2020 by Daniel Getts.

Daniel Getts inFounder and CEODaniel Getts is founder and CEO of CREATE Medicines, a clinical-stage biotech company developing in vivo mRNA immune cell programming therapies for cancer, autoimmune disease, and transplant rejection.

Brett KaplaninChief Financial and Business Officer

Marcus LoweNamed on SEC filing

Dhruv AminNamed on SEC filing

Investors · 3

8VCAustin · $100K – $50M

Raptor GroupMiami Beachvia James J. Pallotta · inferred

Newpath PartnersreportedBoston · $50K – $10M

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 1 round · 2022

▶$2MraisedNov 2022 · 1 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Marcus LoweExecutive Officer, Director
Dhruv AminExecutive Officer, Director

Offering amount: $3M
Amount sold: $2M
First sale: Nov 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Bioworld84 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Eli Lilly73 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

Companies competing with Create for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Create do?: CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
Who founded Create?: Create was founded by Daniel Getts in 2020.
Who are Create's investors?: Create's investors include 8VC, Raptor Group, Newpath Partners.
How much funding has Create raised?: Create has disclosed $2M raised across 1 round.
Where is Create headquartered?: Create is headquartered in San Francisco, US.